Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients (GL-CLB-001)
This study has been terminated.
(Unsatisfactory enrollment)
Sponsor:
Jewish General Hospital
Collaborator:
Novartis Pharmaceuticals
Information provided by:
Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT00558961
First received: November 15, 2007
Last updated: April 14, 2010
Last verified: November 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been terminated. |
|---|---|
| Study Completion Date: | April 2009 |
| Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |